Chinese Journal of Pharmacovigilance ›› 2014, Vol. 11 ›› Issue (2): 88-93.

Previous Articles     Next Articles

Role of Drug Manufacturers in Post-marketed Drug Risk Management

REN Jing-tian1, ZHENG Wen-ke2, ZHANG Jun-hua2, LEI Xiang2, YANG Le1, GUO Xiao-xin1, SHANG Hong-cai2, *, DU Xiao-xi1, *   

  1. 1 Center for Drug Reevaluation, CFDA, Beijing 100045;
    2Tianjin University of Traditional Chinese Medicine, Tianjin, 300193
  • Received:2013-01-16 Revised:2016-02-03 Online:2014-02-08 Published:2016-02-03

Abstract: According to the content of risk management guidances in EU and USA, and spirit of ICH document, this paper puts forward that drug risk management includes risk information collection, risk identification, risk evaluation, risk management and evaluation of the effectiveness on risk management measures. This paper also puts emphasis on the responsibility of drug manufacturers, which should be implemented on risk management.

Key words: drug, drug manufacturers, risk management, responsibility of manufacturers

CLC Number: